Private Market View

Greenstone Biosciences

Palo Alto, CA · Founded 2021 · Privately Held (backing)

Last price · $/share
Implied valuation
$123.0M
Total raised
$20.2M
Last round
Early Stage VC
Apr 2022
What is Greenstone Biosciences worth?
$123.0Mlast known valuation

Greenstone Biosciences last raised $10.2M in its Early Stage VC (Apr 2022).

Free account
See the evidence behind this price
  • ·Post-money valuations for all 1 rounds
  • ·The complete investor list — 5 names
  • ·Watchlist + deal alerts for Greenstone Biosciences
Create free account
No card required

Funding history

1 rounds
DateRoundRaisedPost-money
Apr 2022Early Stage VC$10.2M

How Greenstone Biosciences's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Greenstone Biosciences, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked

What is Greenstone Biosciences worth?
Greenstone Biosciences's last known valuation is $123.0M.
How much has Greenstone Biosciences raised?
Greenstone Biosciences has raised $20.2M in total funding across 1 recorded rounds.
When did Greenstone Biosciences last raise?
Greenstone Biosciences last raised in Apr 2022 (Early Stage VC), raising $10.2M.